McKew John C. — SEC Form 4 filings

SEC reporting owner CIK 1640560. 6 Form 4 filings on record with FilingPulse; latest filed 2024-12-13.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-05 to 2024-12-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LUMOS PHARMA, INC.Chief Scientific Officer63 legs · 6,059 sh · $13,89714

Form 4 filings — McKew John C.

FiledFormIssuerReported transactionsSource
2024-12-134LUMOS PHARMA, INC.Disposition to issuer (D): 13,153 · Disposition to issuer (D): 16,000 (derivative) · Disposition to issuer (D): 16,000 (derivative) · Disposition to issuer (D): 6,541 (derivative) · Disposition to issuer (D): 9,583 (derivative) · Disposition to issuer (D): 81,690 (derivative) · +3 moreEDGAR
2024-08-064LUMOS PHARMA, INC.Sale (S): 3,407 @ $1.89EDGAR
2024-08-054LUMOS PHARMA, INC.Tax withholding (F): 1,593 @ $1.79EDGAR
2024-04-034LUMOS PHARMA, INC.Grant/award (A): 2,000 @ $2.84 · Tax withholding (F): 1,036 @ $2.84 · Sale (S): 2,214 @ $2.77 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2024-02-074LUMOS PHARMA, INC.Sale (S): 438 @ $3.03EDGAR
2024-02-054LUMOS PHARMA, INC.Tax withholding (F): 366 @ $3.01EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1640560 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →